Max Robotics — Global Service Robot Directory + US Certification

About

G. Altenstein is a leading figure in radiation oncology, with a primary focus on stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC). Their most influential work, the 2017 "Planning benchmark study for SBRT of early stage NSCLC," has garnered 54 citations and serves as a critical reference for standardizing treatment planning protocols. This study systematically evaluated dosimetric parameters across institutions, helping to establish consensus guidelines that improve tumor control while minimizing toxicity to healthy lung tissue. Altenstein's contributions have directly shaped clinical practice by providing a reproducible framework for SBRT delivery, enhancing both safety and efficacy. Their research is widely recognized for bridging the gap between technical planning and patient outcomes, making them a trusted authority in lung cancer radiotherapy. With a career dedicated to refining precision oncology, Altenstein continues to influence how radiation is planned and delivered, ensuring that patients benefit from the most advanced, evidence-based approaches. Their work remains essential reading for clinicians and researchers seeking to optimize SBRT for early-stage NSCLC.